KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Return on Assets (2016 - 2025)

Acadia Pharmaceuticals (ACAD) has 15 years of Return on Assets data on record, last reported at 0.11% in Q4 2025.

  • For Q4 2025, Return on Assets rose 6.0% year-over-year to 0.11%; the TTM value through Dec 2025 reached 0.11%, up 6.0%, while the annual FY2025 figure was 0.28%, 5.0% up from the prior year.
  • Return on Assets reached 0.11% in Q4 2025 per ACAD's latest filing, up from 0.08% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.14% in Q3 2024 and bottomed at 0.36% in Q4 2022.
  • Average Return on Assets over 5 years is 0.14%, with a median of 0.2% recorded in 2023.
  • Peak YoY movement for Return on Assets: decreased -13bps in 2022, then soared 37bps in 2024.
  • A 5-year view of Return on Assets shows it stood at 0.24% in 2021, then plummeted by -53bps to 0.36% in 2022, then skyrocketed by 76bps to 0.09% in 2023, then skyrocketed by 151bps to 0.04% in 2024, then soared by 140bps to 0.11% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.11% in Q4 2025, 0.08% in Q3 2025, and 0.05% in Q2 2025.